---
figid: PMC8147889__JHC-8-435-g0003
figtitle: Mechanisms of HBV-Induced Hepatocellular Carcinoma
organisms:
- NA
pmcid: PMC8147889
filename: JHC-8-435-g0003.jpg
figlink: /pmc/articles/PMC8147889/figure/f0003/
number: F3
caption: HBV is involved in activation of cancer-related signaling pathways. (A) Wnt/β-catenin
  signalling pathway. HBV can activate Wnt/β-catenin signaling by activating TCF or
  inhibiting GSK3β; HBx can silence the SFRPs to activate Wnt signaling; HBx promotes
  the disintegration of the E-cadherin complex with β-catenin; HBsAg can up–regulate
  the expression of LEF-1. (B) PI3K/AKT signalling pathway. HBx can inhibit PTEN,
  a suppressor of PIP3; HBx and HBx mutant can activate Akt directly. (C) MAPK/ERK
  signalling pathway. HBx can activate Ras and ERK directly; HBx can activate ERK
  by activating Notch signal. (D) Oxidative stress pathways. The structural proteins
  of HBV, HBx, HBS and HBC, can induce ROS production. ROS has been shown to play
  a direct promoting role in viral replication and malignant transformation. ROS can
  activate KEAP1/NRF2/ARE pathway, which plays an important role in resistance to
  ROS. Lines ending with arrows or bars indicate activating or inhibitory effects
  respectively.
papertitle: The Mechanisms of HBV-Induced Hepatocellular Carcinoma.
reftext: Yu Jiang, et al. J Hepatocell Carcinoma. 2021;8:435-450.
year: '2021'
doi: 10.2147/JHC.S307962
journal_title: Journal of Hepatocellular Carcinoma
journal_nlm_ta: J Hepatocell Carcinoma
publisher_name: Dove
keywords: hepatocellular carcinoma | hepatitis B virus | carcinogenic mechanisms |
  therapy
automl_pathway: 0.9477817
figid_alias: PMC8147889__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8147889__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8147889__JHC-8-435-g0003.html
  '@type': Dataset
  description: HBV is involved in activation of cancer-related signaling pathways.
    (A) Wnt/β-catenin signalling pathway. HBV can activate Wnt/β-catenin signaling
    by activating TCF or inhibiting GSK3β; HBx can silence the SFRPs to activate Wnt
    signaling; HBx promotes the disintegration of the E-cadherin complex with β-catenin;
    HBsAg can up–regulate the expression of LEF-1. (B) PI3K/AKT signalling pathway.
    HBx can inhibit PTEN, a suppressor of PIP3; HBx and HBx mutant can activate Akt
    directly. (C) MAPK/ERK signalling pathway. HBx can activate Ras and ERK directly;
    HBx can activate ERK by activating Notch signal. (D) Oxidative stress pathways.
    The structural proteins of HBV, HBx, HBS and HBC, can induce ROS production. ROS
    has been shown to play a direct promoting role in viral replication and malignant
    transformation. ROS can activate KEAP1/NRF2/ARE pathway, which plays an important
    role in resistance to ROS. Lines ending with arrows or bars indicate activating
    or inhibitory effects respectively.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDH1
  - CTNNB1
  - LRP6
  - LRP5
  - HNF4A
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - KRAS
  - HRAS
  - NRAS
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - ADAR
  - DVL1P1
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - CHKA
  - MYC
  - CCN5
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - JUN
  - STAT3
  - CCND1
  - EPHB2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - GAB1
  - PIGU
  - GAB2
  - MMUT
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IRS1
  - PDK1
  - PDPK1
  - KEAP1
  - GABPA
  - NFE2L2
  - FOXO1
  - MAF
  - MAFA
  - MAFB
  - MAFF
  - MAFG
  - MAFK
  - AKT1
  - AKT2
  - AKT3
  - PTEN
  - KRT88P
---
